555
Participants
Start Date
July 31, 2004
Study Completion Date
March 31, 2006
Tesaglitazar 0.5 or 1 mg
Glibenclamide 2.5, 5, 10 or 15 mg
Research Site, Adelaide
Research Site, Brisbane
Research Site, Cairns
Research Site, Geelong
Research Site, Melbourne
Research Site, Perth
Research Site, Sydney
Research Site, Tasmania
Research Site, Angers
Research Site, Hyères
Research Site, La Garde
Research Site, La Seyne-sur-Mer
Research Site, Laval
Research Site, Le Brusc
Research Site, Le Lavandou
Research Site, Montrevault
Research Site, Paris
Research Site, Saint-Cyr
Research Site, Six-Fours-les-Plages
Research Site, Tiercé
Research Site, Toulon
Research Site, Ashkelon
Research Site, Haifa
Research Site, Holon
Research Site, Jerusalem
Research Site, Rishon LeZiyyon
Research Site, Safed
Research Site, Tel Aviv
Research Site, Tel Litwinsky
Research Site, Bergen
Research Site, Elverum
Research Site, Enebakk
Research Site, Fredrikstad
Research Site, Gamle Fredrikstad
Research Site, Hamar
Research Site, Haugesund
Research Site, Hurdal
Research Site, Inderøy
Research Site, Lena
Research Site, Levanger
Research Site, Oslo
Research Site, Rud
Research Site, Sedsmokorset
Research Site, Soerumsand
Research Site, Stavanger
Research Site, Manila
Research Site, Marikina City
Research Site, Pasig
Research Site, Cape Town
Research Site, Chatsworth
Research Site, Gauteng
Research Site, Pretoria
Research Site, Seoul
Research Site, Suwon
Research Site, Alzira (Valencia)
Research Site, Barcelona
Research Site, Guissona (Lleida)
Research Site, Madrid
Research Site, San Sebastian de Los Reyes ( Madrid)
Research Site, San Vicente de Raspeig (Alicante)
Research Site, Valencia
Research Site, Dublin
Research Site, Aberdeen
Research Site, Barnsley
Research Site, Bath
Research Site, Belfast
Research Site, Birmingham
Research Site, Cardiff
Research Site, Coventry
Research Site, Dundee
Research Site, East Sussex
Research Site, Edinburgh
Research Site, Glasgow
Research Site, Leeds
Research Site, Liverpool
Research Site, London
Research Site, Manchester
Research Site, Shrewsbury
Research Site, Surrey
Research Site, West Midlands
Research Site, Wiltshire
Research Site, Wrexham
Research Site, Hanoi
Research Site, Ho Chi Minh City
Lead Sponsor
AstraZeneca
INDUSTRY